The antihypertensive effects of ketanserin (R 41468), a novel 5-hydroxytryptamine-blocking agent, in patients with essential hypertension. 1981

J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007650 Ketanserin A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione,R-41,468,R-41468,R 41,468,R 41468,R41,468,R41468
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010880 Piperidines A family of hexahydropyridines.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
July 1982, The Journal of pharmacy and pharmacology,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
August 1983, British journal of clinical pharmacology,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
August 1984, Naunyn-Schmiedeberg's archives of pharmacology,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
February 1983, Archives internationales de pharmacodynamie et de therapie,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
January 1984, Critical care medicine,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
April 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
August 1988, Journal of human hypertension,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
January 1987, Journal of cardiovascular pharmacology,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
January 1987, European journal of clinical pharmacology,
J De Crée, and J Leempoels, and H Geukens, and W De Cock, and H Verhaegen
January 1989, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!